文献速递神经肿瘤

NQO1介导的氧化应激抵抗与胶质母细胞瘤微环境重塑

NAD(P)H: quinone oxidoreductase 1-mediated oxidative stress resistance and tumor microenvironment remodeling in glioblastoma.
PubMed 文献 · Neuro Oncol · 2026-01-01

该研究通过蛋白质组学、表观遗传分析和单细胞RNA测序,发现NQO1在胶质母细胞瘤干细胞中高表达,可调控活性氧水平、维持核纤层蛋白B1稳定性并抑制cGAS-I型干扰素信号,从而重塑免疫抑制微环境。NRF2转录调控NQO1。靶向NQO1及其下游信号(如β-拉帕醌和抗PD-1治疗)为GBM临床干预提供新思路。

要点

  • NQO1在胶质母细胞瘤干细胞中优先表达并调控ROS水平。
  • NQO1维持核纤层蛋白B1稳定性,抑制cGAS-I型干扰素信号。
  • 靶向NQO1联合抗PD-1治疗是潜在临床干预策略。

核心结论

  • NQO1在细胞自主和细胞外水平均发挥关键作用,靶向NQO1及其下游信号通路(包括β-拉帕醌和抗PD-1免疫检查点抑制剂)为GBM临床干预提供新途径。

研究设计与样本

  • 采用蛋白质组学分析、H3K27ac ChIP测序和单细胞RNA测序定义NQO1在GBM中的高富集。
  • 进行体外和体内功能缺失遗传学及药理学实验评估NQO1对GSC增殖和自我更新的影响。
  • 使用患者来源GSC和异种移植小鼠模型研究肿瘤内在和外在机制。

主要发现

  • NQO1在GSC中优先表达并调控ROS水平,维持核Lamin B1稳定性,抑制cGAS-I型干扰素信号,有助于重塑免疫抑制TME。
  • NRF2转录调控NQO1,抑制I型干扰素信号。

临床怎么用

  • 靶向NQO1及其下游信号通路,包括β-拉帕醌和免疫检查点抑制剂如抗PD-1治疗,可能增强GBM治疗效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Glioblastoma (GBM) is a highly aggressive brain tumor, with glioblastoma stem cells (GSCs) occupying the pinnacle of a complex tumor microenvironment (TME), conferring therapeutic resistance. The TME plays a role in tumor development by creating a niche rich in reactive oxygen species (ROS) through oxidative stress (OS). Here, we identified NAD(P)H: quinone oxidoreductase 1 (NQO1) as an essential regulatory factor in antioxidant stress response, which is key to maintaining GSCs and the immunosuppressive TME. METHODS: Proteomics analysis and epigenetic profiling using H3K27ac ChIP-sequencing and single-cell RNA sequencing were performed to define the high enrichment of NQO1 in GBM. In vitro and in vivo loss-of-function genetic and pharmacologic assays were conducted to evaluate the effect of NQO1 in GSC proliferation and self-renewal. Patient-derived GSCs and xenograft murine models were using to investigate the tumor-intrinsic and extrinsic mechanisms to confers resistance to OS and reprogram the immunosuppressive TME. RESULTS: NQO1 was preferentially expressed in GSCs and regulated ROS levels, preserving the stability of nuclear Lamin B1 and inhibiting cGAS-type I interferon signaling, which helps to remodel the immunosuppressive TME. Furthermore, nuclear factor erythroid 2-related factor 2 (NRF2) transcriptionally regulates NQO1, suppressing type I interferon signaling. CONCLUSIONS: NQO1 plays critical roles at both the cell-autonomous and cell-extrinsic levels for clinical treatment. Targeting NQO1 and its downstream signaling pathways, including β-lapachone and immune checkpoint inhibitors such as anti-PD-1 therapy, enhances our understanding of the interactions between GSCs, OS, and the TME. This offers promising new avenues for clinical intervention in GBM.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Li Y, Kang T, Jia Z, et al. NAD(P)H: quinone oxidoreductase 1-mediated oxidative stress resistance and tumor microenvironment remodeling in glioblastoma. Neuro Oncol. 2026. PMID: 41738493. doi:10.1093/neuonc/noag015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。